May 06, 2026

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

Caris MI Clarity leverages AI to transform how recurrence risk is understood and applied in postmenopausal patients with HR-positive/HER2-negative, node-negative early-stage breast cancer IRVING, Texas, May 5, 2026 /PRNewswire/ -- Caris Life Sciences®...

recent articles

by Elaine Armstrong | July 15, 2020 Medical informatics and imaging technology company, Cirdan has today announced that it has acquired the Belfast-based Philips Digital and Computational Pathology business (formerly known as...

Pittsburgh, PA, July 7, 2020 – SpIntellx, Inc., and CellNetix Pathology & Laboratories have announced that they will collaborate to validate the SpIntellx HistoMapr-Breast™ Platform, which taps the power of explainable artificial...

July 15, 2020 - Deciphex an Irish based technology player, developing ergonomic digital pathology workflows and AI for histopathology, has announced the conclusion of a $6.2m Series A fundraising which will empower the company to...

Going digital under pressure is hard. COVID-19 has forced every health institution in the country to consider adopting digital tools, both as a social distancing measure and a core productivity tool for these uncertain times. With elective...

  Slide viewing interface substantially improves the ergonomics of digital pathology Concord, MA (July 14, 2020) - Corista, an integrated pathology solutions leader, has received a USPTO patent grant for its new Virtual Slide...

Company’s continued product portfolio of innovation in telepathology and digital diagnostics accelerated by further investment   NEW YORK, July 13, 2020 – Paige, a global leader in computational pathology, today announced it received...

OR

platinum partners

gold partners

Silver Partners

Media Partners